These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33278602)

  • 1. Nanodelivery of immunogenic cell death-inducers for cancer immunotherapy.
    Sun D; Zhang J; Wang L; Yu Z; O'Driscoll CM; Guo J
    Drug Discov Today; 2021 Mar; 26(3):651-662. PubMed ID: 33278602
    [No Abstract]   [Full Text] [Related]  

  • 2. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
    Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
    Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
    Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV
    Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.
    Duan X; Chan C; Lin W
    Angew Chem Int Ed Engl; 2019 Jan; 58(3):670-680. PubMed ID: 30016571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting immunogenic cell stress and death for cancer therapy.
    Galluzzi L; Guilbaud E; Schmidt D; Kroemer G; Marincola FM
    Nat Rev Drug Discov; 2024 Jun; 23(6):445-460. PubMed ID: 38622310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy.
    Xu W; Liu W; Yang J; Lu J; Zhang H; Ye D
    Immunol Rev; 2024 Jan; 321(1):181-198. PubMed ID: 37403660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
    Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
    J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapy.
    Li W; Jiang Y; Lu J
    Int J Pharm; 2023 Mar; 634():122655. PubMed ID: 36720448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural modulators of the hallmarks of immunogenic cell death.
    Radogna F; Dicato M; Diederich M
    Biochem Pharmacol; 2019 Apr; 162():55-70. PubMed ID: 30615863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death.
    Chen Q; Li C; Wang Q
    Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Immunotherapy Elicited by Immunogenic Cell Death Based on Smart Nanomaterials.
    Yang M; Zhang C; Wang R; Wu X; Li H; Yoon J
    Small Methods; 2023 May; 7(5):e2201381. PubMed ID: 36609838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting dendritic cell metabolism in cancer.
    Zitvogel L; Kroemer G
    Nat Med; 2010 Aug; 16(8):858-9. PubMed ID: 20689548
    [No Abstract]   [Full Text] [Related]  

  • 14. Local Drug Delivery Techniques for Triggering Immunogenic Cell Death.
    Ren E; Wang Y; Liang T; Zheng H; Shi J; Cheng Z; Li H; Gu Z
    Small Methods; 2023 Sep; 7(9):e2300347. PubMed ID: 37259275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering immunogenic cell death with nanosized drug delivery systems improving cancer immunotherapy.
    Yan W; Lang T; Qi X; Li Y
    Curr Opin Biotechnol; 2020 Dec; 66():36-43. PubMed ID: 32673944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric Nanosystems for Immunogenic Cell Death-Based Cancer Immunotherapy.
    Fu L; Zhou X; He C
    Macromol Biosci; 2021 Jul; 21(7):e2100075. PubMed ID: 33885225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining Mechanical High-Intensity Focused Ultrasound Ablation with Chemotherapy for Augmentation of Anticancer Immune Responses.
    Li C; Lu Y; Cheng L; Zhang X; Yue J; Liu J
    Mol Pharm; 2021 May; 18(5):2091-2103. PubMed ID: 33886331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
    Qi J; Jin F; Xu X; Du Y
    Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
    Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
    ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of annexin A1 release during immunogenic cell death.
    Baracco EE; Petrazzuolo A; Kroemer G
    Methods Enzymol; 2019; 629():71-79. PubMed ID: 31727257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.